Non-alcoholic Steatohepatitis (NASH)
SCIENTIFIC ANIMATION
Random42 produced this Mechanism of Disease (MoD) animation for Pfizer to take a closer look at Non-alcoholic steatohepatitis (NASH). NASH is liver inflammation and damage caused by an excess build-up of fat in the liver. It is the most severe form of non-alcoholic fatty liver disease (NAFLD) and has links with obesity, metabolic syndrome, diabetes, or a genetic predisposition.
NASH is an unfamiliar disease to many patients and can be initially unrecognized by physicians. Pfizer is committed to advancing the understanding and treatment of this disease, with this animation adding to the efforts of understanding the science of NASH through visually engaging scientific storytelling.
This animation is hosted on the Pfizer website as a featured News segment, ‘A Closer Look at NASH’.
Are you interested in seeing how our award-winning medical animation can help you?
Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.
TESTIMONIALS
‘‘For experts, there’s limited time in which they will interact with this content, so getting a message across quickly is crucial, and this medium does it very well.’’
Product Manager, GSK
‘‘Their turnaround time sets them apart from the rest of the field. The fact they can turnaround lots of comments in a couple of days is impressive, whereas that took weeks with other agencies we worked with. They’re well above the benchmark.’’
Oncology Clinical Liaison, Bristol-Myers Squibb
‘‘It was a combination equally of quality of work but also the comfort and confidence that I knew I would be working with PhDs. They gave me the confidence that they would have the ability to understand. The other companies didn’t have those sorts of people on staff, they were just good animators. That was the area where I felt that I could trust Random42 would deliver.’’
Senior Product Manager, Spectranetics
‘‘I have been to a lot of conferences and I have seen a lot of videos both from competitors and internally – in my eyes it is night and day. The quality Random42 have is not one step ahead, it is far ahead compared to what I have seen before.’’
Product Manager, Amgen
